The safety and efficacy of gemcitabine and cisplatin (GP)‐based induction chemotherapy plus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a meta‐analysis

被引：0
|
作者：
Min Tang
Zhongxiong Jia
Ju Zhang
机构：
[1] The First Affiliated Hospital of Chongqing Medical University,Department of Oncology
[2] The First Affiliated Hospital of Chongqing Medical University,Department of Orthopedics
来源：
European Archives of Oto-Rhino-Laryngology | 2022年 / 279卷
关键词：
Nasopharyngeal carcinoma; Induction chemotherapy; Chemoradiotherapy; Gemcitabine; Cisplatin; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1561 / 1572
页数：11
相关论文
共 50 条
  • [1] The safety and efficacy of gemcitabine and cisplatin (GP)-based induction chemotherapy plus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a meta-analysis
    Tang, Min
    Jia, Zhongxiong
    Zhang, Ju
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2022, 279 (03) : 1561 - 1572
  • [2] The efficacy and safety of docetaxel, cisplatin and fluorouracil (TPF)-based induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis
    Zhou, R.
    Zhu, J.
    Chen, X.
    Liu, Y.
    Wang, Y.
    Zhang, T.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (03): : 429 - 439
  • [3] The efficacy and safety of docetaxel, cisplatin and fluorouracil (TPF)-based induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis
    R. Zhou
    J. Zhu
    X. Chen
    Y. Liu
    Y. Wang
    T. Zhang
    [J]. Clinical and Translational Oncology, 2020, 22 : 429 - 439
  • [4] The efficacy and toxicity of induction chemotherapy plus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma A meta-analysis of randomized controlled trials
    Wang, Peirong
    Zhang, Mingwei
    Ke, Chunlin
    Cai, Chuanshu
    [J]. MEDICINE, 2020, 99 (10) : E19360
  • [5] Randomized Phase II Trial of Gemcitabine and Cisplatin (GP) versus Docetaxel and Cisplatin (TP) as Induction Chemotherapy followed by Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
    Zang, J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S106 - S106
  • [6] Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
    Zhen Zeng
    Ruo-Nan Yan
    Li Tu
    Yu-Yi Wang
    Pei-Ran Chen
    Feng Luo
    Lei Liu
    [J]. Scientific Reports, 8
  • [7] Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
    Zeng, Zhen
    Yan, Ruo-Nan
    Tu, Li
    Wang, Yu-Yi
    Chen, Pei-Ran
    Luo, Feng
    Liu, Lei
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [8] Is Gemcitabine and Cisplatin induction chemotherapy superior in locoregionally advanced nasopharyngeal carcinoma?
    Zheng, Wei
    Qiu, Sufang
    Huang, Lingling
    Pan, Jianji
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2015, 31 (04) : 781 - 786
  • [9] A meta-analysis comparing the efficacy and safety of gemcitabine plus cisplatin induction chemotherapy in patients with locoregionally advanced NPC
    Lifeng Xiao
    Wenyi Kang
    Jiayu Liao
    Yuru Li
    [J]. European Archives of Oto-Rhino-Laryngology, 2022, 279 : 2441 - 2450
  • [10] A meta-analysis comparing the efficacy and safety of gemcitabine plus cisplatin induction chemotherapy in patients with locoregionally advanced NPC
    Xiao, Lifeng
    Kang, Wenyi
    Liao, Jiayu
    Li, Yuru
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2021, 279 (5) : 2441 - 2450
12345